Federica Gemignani Selected Research

Federica Gemignani Research Topics

Disease

33	Neoplasms (Cancer) 05/2022 - 08/2002
21	Malignant Mesothelioma 05/2022 - 06/2007
10	Colorectal Neoplasms (Colorectal Cancer) 04/2016 - 03/2004
5	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 12/2011
5	Multiple Myeloma 01/2021 - 03/2013
5	Carcinogenesis 01/2020 - 01/2008
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 03/2007
3	Genetic Predisposition to Disease (Genetic Predisposition) 03/2012 - 03/2008
3	Lung Neoplasms (Lung Cancer) 07/2008 - 10/2005
2	Spastic ataxia Charlevoix-Saguenay type 01/2022 - 01/2020
2	Infections 11/2016 - 03/2008
2	Genomic Instability 04/2016 - 12/2009
2	Carcinoma (Carcinomatosis) 01/2014 - 03/2007
2	beta-Thalassemia (Cooley's Anemia) 01/2003 - 11/2002
1	Neurodevelopmental Disorders 09/2021
1	Ataxia (Dyssynergia) 09/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2021
1	Occupational Diseases (Occupational Disease) 01/2021
1	recessive Spastic paraplegia type 5A 01/2020
1	Endometriosis 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Mesothelioma 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Thyroid Diseases (Thyroid Disease) 12/2016
1	Pancreatitis 11/2016
1	Obesity 11/2016
1	Gallstones (Gallstone) 11/2016
1	Acidosis 03/2016
1	Overweight 06/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2014
1	Disease Susceptibility (Diathesis) 01/2014
1	Asbestosis 07/2008
1	Mycoses (Diseases, Fungus) 03/2008
1	Adenoma (Adenomas) 03/2007
1	Inflammation (Inflammations) 03/2007

Drug/Important Bio-Agent (IBA)

14	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2008
10	AsbestosIBA 01/2021 - 06/2007
8	MesothelinIBA 01/2020 - 04/2010
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2010
6	3' Untranslated Regions (3' UTR)IBA 01/2021 - 01/2008
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2014
5	XenobioticsIBA 03/2013 - 08/2002
4	Peptides (Polypeptides)IBA 01/2020 - 04/2011
3	Messenger RNA (mRNA)IBA 01/2020 - 03/2004
3	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2008
3	EnzymesIBA 12/2009 - 10/2006
3	OligonucleotidesIBA 03/2008 - 10/2003
2	Tumor Biomarkers (Tumor Markers)IBA 05/2021 - 04/2011
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 11/2020 - 01/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2016
2	Codon (Codons)IBA 12/2011 - 03/2004
2	NucleotidesIBA 04/2006 - 01/2003
2	A-Form DNA (A-DNA)IBA 08/2004 - 11/2002
1	alexidineIBA 05/2022
1	CaspasesIBA 05/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	coenzyme Q10 (CoQ10)IBA 09/2021
1	Circulating Tumor DNAIBA 05/2021
1	Risedronic Acid (Actonel)FDA LinkGeneric 01/2021
1	Galectin 3 (LGALS3)IBA 01/2021
1	fludarabineIBA 01/2021
1	Adaptor Protein Complex 4IBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2019
1	LuciferasesIBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 01/2019
1	Immunoglobulin M (IgM)IBA 02/2017
1	crenolanibIBA 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	Hormones (Hormone)IBA 12/2016
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 12/2016
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 04/2016
1	Transcription Factors (Transcription Factor)IBA 03/2016
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2015
1	telomerase RNA (bTR)IBA 03/2015
1	ORALIT (ORS)IBA 06/2014
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2014
1	Fluorouracil (Carac)FDA LinkGeneric 11/2013
1	Genetic Markers (Genetic Marker)IBA 12/2011
1	Proline (L-Proline)FDA Link 12/2011
1	Mineral Fibers (Mineral Fiber)IBA 03/2008
1	DNA (Deoxyribonucleic Acid)IBA 03/2008
1	Untranslated Regions (Untranslated Region)IBA 03/2008
1	Small Untranslated RNAIBA 03/2008
1	Superoxide DismutaseIBA 06/2007
1	glutathione S-transferase M1IBA 06/2007
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 06/2007
1	Nucleic AcidsIBA 06/2007
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 03/2007
1	Interleukin-4 (Interleukin 4)IBA 03/2007
1	SmokeIBA 11/2006
1	CarcinogensIBA 10/2006

Therapy/Procedure

9	Therapeutics 05/2022 - 11/2013
4	Drug Therapy (Chemotherapy) 01/2017 - 04/2006
1	Immunotherapy 01/2022
1	Cholecystectomy 11/2016